Midtown-based Dianthus Therapeutics announced a $625 million public offering this week to raise capital for anti-inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results